Patent: 9,993,553
✉ Email this page to a colleague
Summary for Patent: 9,993,553
Title: | Methods and compositions for targeted release of molecules from nanoscale carriers |
Abstract: | The present disclosure relates generally to the field of nanoscale materials, and more specifically to the field of nanoscale materials for activating delivered molecules at a target location. |
Inventor(s): | Guo; Ting (Davis, CA), Starkewolfe; Zane B. (Davis, CA) |
Assignee: | The Regents of the University of California (Oakland, CA) |
Application Number: | 14/213,148 |
Patent Claims: | see list of patent claims |
Details for Patent 9,993,553
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Acrotech Biopharma Llc | ZEVALIN | ibritumomab tiuxetan | Injection | 125019 | 02/19/2002 | ⤷ Try a Trial | 2033-03-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |